Results 141 to 150 of about 1,825,876 (215)

Corrigendum to 'Analgesic-loaded NIR-II photothermal hydrogel for efficient anti-infection and precise pain management in wounds' [Mater. Today Bio 37 (2026) 102995]. [PDF]

Mater Today Bio
Zhou N, Wang W, Xu L, Zhang A, Lu X, Chen YP, Fan S, Zhang T, Yu C, Wang XQ, Fu D.   +10 more
europepmc   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

Molecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht, Sameer Gupta, Amrita Chaurasia, Manisha Sachan   +3 more
wiley   +1 more source

Correction: Maternal intestinal L. vaginalis facilitates embryo implantation and survival through enhancing uterine receptivity in sows. [PDF]

Microbiome
Ye Q, Hu Y, Jiang H, Luo T, Han L, Chen Y, Chen J, Ma L, He Z, Yan X.   +9 more
europepmc   +1 more source

Editorial: Engineering technology and engineering: incorporating the humanities into the classroom

Frontiers in Education
Anne M. Lucietto, Diane Peters
doaj   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

Retraction Note: Nano-Bio Soil Improvement (NBSI) with Micro-, Nano-, and Pico- Typha latifolia: a green material approach. [PDF]

Sci Rep
Zeynali Y, Niroumand H, Moayed RZ.
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Retraction Note: Predicting the compressive strength of polymer-infused bricks: A machine learning approach with SHAP interpretability. [PDF]

Sci Rep
Chandra SS, Kumar R, Arjunasamy A, Galagali S, Tantri A, Naganna SR.   +5 more
europepmc   +1 more source

Izdavačka djelatnost Fakulteta kemijskog inženjerstva i tehnologije! Edicija ISTAKNUTI PROFESORI [PDF]

Kemija u Industriji, 2008
Kastelan-Macan, Marija, Grzetic, Vesna
doaj  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source